Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
View/ Open
Volume
387
Pagination
866 - 873
DOI
10.1016/S0140-6736(15)01129-0
Journal
LANCET
Issue
ISSN
0140-6736
Metadata
Show full item recordAuthors
Forbes, JF; Sestak, I; Howell, A; Bonanni, B; Bundred, N; Levy, C; von Minckwitz, G; Eiermann, W; Neven, P; Stierer, MCollections
- Centre for Cancer Prevention [1179]